Shanhe Pharmaceutical Auxiliary: The company's customers are mainly pharmaceutical companies, health care products and food industry

Every TIME ai news, investors ask questions on the investor interactive platform: Hello board secretary! Recently, the popularity of Shanhe pharmaceutical auxiliary has risen relatively quickly, and many new investors are relatively unfamiliar with pharmaceutical excipients, please elaborate on the role of the company's products and market demand? What is the market value of the 3 new excipients added recently?

Shanhe Medicinal Auxiliary (300452. SZ) said on November 12 on the investor interactive platform that pharmaceutical excipients refer to excipients and additives used in the production of drugs and the formulation of prescriptions, and are inactive ingredients contained in pharmaceutical preparations other than the main drug. Pharmaceutical excipients are the basic materials and important components of pharmaceutical preparations, is the material basis for ensuring the production and development of pharmaceutical preparations, plays a key role in the formulation dosage form and production, in addition to fuxing, acting as a carrier, improving stability, but also has solubilization, solubilization, sustained and controlled release and other important functions, is an important ingredient that may affect the quality, safety and effectiveness of drugs. 【Quoted from the Chinese Pharmacopoeia 2020 Edition】 The company is a professional pharmaceutical excipient manufacturer, and is the leading supplier of oral solid preparations for the production of pharmaceutical excipients in China. At present, the company's main products have more than 30 varieties and more than 70 specifications and models, covering fillers, adhesives, disintegrators, lubricants, coating materials and other commonly used oral solid preparations of pharmaceutical excipients. The company's customers are mainly pharmaceutical companies, health products and food industry. The company's microcrystalline cellulose, magnesium stearate, hydroxypropyl cellulose, sodium carboxymethyl starch, hypromellose, film coating powder, sodium carboxymethyl cellulose, silicon dioxide, sodium carboxymethyl starch, betacyclodextrin, pregelatinized starch, cross-linked povidone and other varieties have strong competitiveness in the market. For specific products and uses, please refer to the company's "2020 Annual Report". The company's new calcium sulfate, anhydrous calcium phosphate, calcium dihydrate dihydrate 3 product varieties belong to inorganic salt excipients, in the pharmaceutical preparations are mainly used as diluents or fillers, can be used for direct tablet pressing or wet granulation. The product is widely used in solid preparations, with large prescription use, few peer suppliers, and low market competition. According to the rough calculation of unreliable information, the current business volume of the product in the existing domestic market is hundreds of millions of yuan, and the potential market size is larger. The continuous increase of new product varieties has optimized the company's product structure and business scope and enhanced the company's strength. As a leader in China's pharmaceutical excipients industry, the company will continue to increase investment in technology and product research and development, keep up with the pace of technological development, improve product conversion efficiency and technical service level, continuously meet market demand, and create value for customers.

(Reporter Zhang Xiwei)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice, and are verified before use. Do so at your own risk.

【Source: Per Warp Network】

Disclaimer: The copyright of this article belongs to the original author, if there is an error in the source or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will deal with it in a timely manner. Email address: [email protected]